{"id":"https://openalex.org/W2901207337","doi":"https://doi.org/10.1080/19420862.2018.1551044","title":"Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms","display_name":"Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms","alternate_titles":[],"publication_year":2018,"publication_date":"2018-12-10","ids":{"openalex":"https://openalex.org/W2901207337","doi":"https://doi.org/10.1080/19420862.2018.1551044","mag":"2901207337","pmid":"https://pubmed.ncbi.nlm.nih.gov/30466347","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6380427"},"language":"en","primary_location":{"id":"doi:10.1080/19420862.2018.1551044","doi":"https://doi.org/10.1080/19420862.2018.1551044","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2018.1551044","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2901207337"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1080/19420862.2018.1551044","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002595269","display_name":"Ryuta Wada","orcid":"https://orcid.org/0000-0002-0685-853X","observed_orcids":["https://orcid.org/0000-0002-0685-853X"]},"institutions":[{"id":"https://openalex.org/I142395110","display_name":"Astellas Pharma (Japan)","ror":"https://ror.org/01cjash87","country_code":"JP","type":"company","lineage":["https://openalex.org/I142395110"]},{"id":"https://openalex.org/I89630735","display_name":"Yokohama City University","ror":"https://ror.org/0135d1r83","country_code":"JP","type":"education","lineage":["https://openalex.org/I89630735"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ryuta Wada","raw_affiliation_strings":["Department of Medical Life Science, Graduate School of Medical Life Science, Yokohama City University, Tsurumi, Yokohama, Japan","Pharmaceutical Science and Technology Labs., Pharmaceutical Technology, Astellas Pharma, Inc., Tsukuba, Ibaraki, Japan"],"raw_orcid":"https://orcid.org/0000-0002-0685-853X","affiliations":[{"raw_affiliation_string":"Department of Medical Life Science, Graduate School of Medical Life Science, Yokohama City University, Tsurumi, Yokohama, Japan","institution_ids":["https://openalex.org/I89630735"]},{"raw_affiliation_string":"Pharmaceutical Science and Technology Labs., Pharmaceutical Technology, Astellas Pharma, Inc., Tsukuba, Ibaraki, Japan","institution_ids":["https://openalex.org/I142395110"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Makoto Matsui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142395110","display_name":"Astellas Pharma (Japan)","ror":"https://ror.org/01cjash87","country_code":"JP","type":"company","lineage":["https://openalex.org/I142395110"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Makoto Matsui","raw_affiliation_strings":["Pharmaceutical Science and Technology Labs., Pharmaceutical Technology, Astellas Pharma, Inc., Tsukuba, Ibaraki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Science and Technology Labs., Pharmaceutical Technology, Astellas Pharma, Inc., Tsukuba, Ibaraki, Japan","institution_ids":["https://openalex.org/I142395110"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102940193","display_name":"Nana Kawasaki","orcid":"https://orcid.org/0000-0002-5447-1890","observed_orcids":["https://orcid.org/0000-0002-5447-1890"]},"institutions":[{"id":"https://openalex.org/I89630735","display_name":"Yokohama City University","ror":"https://ror.org/0135d1r83","country_code":"JP","type":"education","lineage":["https://openalex.org/I89630735"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nana Kawasaki","raw_affiliation_strings":["Department of Medical Life Science, Graduate School of Medical Life Science, Yokohama City University, Tsurumi, Yokohama, Japan"],"raw_orcid":"https://orcid.org/0000-0002-5447-1890","affiliations":[{"raw_affiliation_string":"Department of Medical Life Science, Graduate School of Medical Life Science, Yokohama City University, Tsurumi, Yokohama, Japan","institution_ids":["https://openalex.org/I89630735"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5002595269"],"corresponding_institution_ids":["https://openalex.org/I142395110","https://openalex.org/I89630735"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":7.0812,"has_fulltext":true,"cited_by_count":207,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98213203,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"11","issue":"2","first_page":"350","last_page":"372"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4839000105857849,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4839000105857849,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.43950000405311584,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.03790000081062317,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/n-glycosylation","display_name":"N-glycosylation","score":0.972000002861023},{"id":"https://openalex.org/keywords/igg1-monoclonal-antibody","display_name":"IgG1 monoclonal antibody","score":0.8970000147819519},{"id":"https://openalex.org/keywords/glycoengineering","display_name":"glycoengineering","score":0.8730000257492065},{"id":"https://openalex.org/keywords/fc-effector-functions","display_name":"Fc effector functions","score":0.9190000295639038},{"id":"https://openalex.org/keywords/fcgammariiia-binding","display_name":"Fc\u03b3RIIIa binding","score":0.8949999809265137},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9819999933242798},{"id":"https://openalex.org/keywords/c1q-binding","display_name":"C1q binding","score":0.9909999966621399},{"id":"https://openalex.org/keywords/fcrn-binding","display_name":"FcRn binding","score":0.9229999780654907},{"id":"https://openalex.org/keywords/thermal-stability","display_name":"thermal stability","score":0.9340000152587891},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.9779999852180481},{"id":"https://openalex.org/keywords/core-fucosylation","display_name":"core fucosylation","score":0.9190000295639038},{"id":"https://openalex.org/keywords/sialylation","display_name":"sialylation","score":0.8920000195503235},{"id":"https://openalex.org/keywords/galactosylation","display_name":"galactosylation","score":0.8619999885559082},{"id":"https://openalex.org/keywords/mannosylation","display_name":"mannosylation","score":0.8920000195503235},{"id":"https://openalex.org/keywords/n-glycan-structure","display_name":"N-glycan structure","score":0.7879999876022339}],"concepts":[{"id":"https://openalex.org/C2777313579","wikidata":"https://www.wikidata.org/wiki/Q898365","display_name":"Glycosylation","level":2,"score":0.8738303780555725},{"id":"https://openalex.org/C2779212266","wikidata":"https://www.wikidata.org/wiki/Q17053974","display_name":"Fucosylation","level":4,"score":0.8390262126922607},{"id":"https://openalex.org/C206212055","wikidata":"https://www.wikidata.org/wiki/Q2553138","display_name":"Glycan","level":3,"score":0.7011860013008118},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.692101240158081},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6816864013671875},{"id":"https://openalex.org/C125823703","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Fragment crystallizable region","level":3,"score":0.6348394155502319},{"id":"https://openalex.org/C158650290","wikidata":"https://www.wikidata.org/wiki/Q3063952","display_name":"Glycome","level":4,"score":0.5538048148155212},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.516247034072876},{"id":"https://openalex.org/C2780649865","wikidata":"https://www.wikidata.org/wiki/Q21101413","display_name":"Neonatal Fc receptor","level":4,"score":0.49545085430145264},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4897308349609375},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.47048047184944153},{"id":"https://openalex.org/C30324644","wikidata":"https://www.wikidata.org/wiki/Q3334151","display_name":"N-linked glycosylation","level":4,"score":0.4530784487724304},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3920142650604248},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.3899761438369751},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2506785988807678},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20621556043624878},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09621986746788025}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006031","descriptor_name":"Glycosylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011134","descriptor_name":"Polysaccharides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D055550","descriptor_name":"Protein Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1080/19420862.2018.1551044","doi":"https://doi.org/10.1080/19420862.2018.1551044","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2018.1551044","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6380427","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6380427/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6380427/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:5381811","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6380427","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:30466347","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30466347","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"},{"id":"mag:3031181442","doi":null,"is_oa":false,"landing_page_url":"https://ycu.repo.nii.ac.jp/index.php?active_action=repository_view_main_item_detail&page_id=4&block_id=67&item_id=1789&item_no=1","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1080/19420862.2018.1551044","doi":"https://doi.org/10.1080/19420862.2018.1551044","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2018.1551044","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.46810001134872437,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2901207337.pdf","grobid_xml":"https://content.openalex.org/works/W2901207337.grobid-xml"},"referenced_works_count":77,"referenced_works":["https://openalex.org/W1191527629","https://openalex.org/W1532698890","https://openalex.org/W1576401981","https://openalex.org/W1862569453","https://openalex.org/W1908224577","https://openalex.org/W1967693680","https://openalex.org/W1971242419","https://openalex.org/W1972352833","https://openalex.org/W1977510035","https://openalex.org/W1977937625","https://openalex.org/W1979162895","https://openalex.org/W1979780600","https://openalex.org/W1992612195","https://openalex.org/W1993024082","https://openalex.org/W2004919864","https://openalex.org/W2008138329","https://openalex.org/W2009155525","https://openalex.org/W2011984976","https://openalex.org/W2015099673","https://openalex.org/W2015723482","https://openalex.org/W2018795884","https://openalex.org/W2023654523","https://openalex.org/W2034515273","https://openalex.org/W2035433348","https://openalex.org/W2044526502","https://openalex.org/W2048087821","https://openalex.org/W2048560240","https://openalex.org/W2049324939","https://openalex.org/W2051666192","https://openalex.org/W2052491267","https://openalex.org/W2057390178","https://openalex.org/W2057745345","https://openalex.org/W2065419141","https://openalex.org/W2067367025","https://openalex.org/W2071843728","https://openalex.org/W2072081310","https://openalex.org/W2078353854","https://openalex.org/W2079579628","https://openalex.org/W2084136419","https://openalex.org/W2088504288","https://openalex.org/W2091435413","https://openalex.org/W2094372926","https://openalex.org/W2103735104","https://openalex.org/W2106183724","https://openalex.org/W2115571948","https://openalex.org/W2119812267","https://openalex.org/W2124847934","https://openalex.org/W2133197373","https://openalex.org/W2134942193","https://openalex.org/W2136007354","https://openalex.org/W2137354517","https://openalex.org/W2140035322","https://openalex.org/W2156471177","https://openalex.org/W2162305597","https://openalex.org/W2190603070","https://openalex.org/W2284695989","https://openalex.org/W2329521420","https://openalex.org/W2335217992","https://openalex.org/W2409183178","https://openalex.org/W2528090859","https://openalex.org/W2596270747","https://openalex.org/W2600329551","https://openalex.org/W2606721249","https://openalex.org/W2616844168","https://openalex.org/W2626288048","https://openalex.org/W2674712403","https://openalex.org/W2741734362","https://openalex.org/W2756044853","https://openalex.org/W2763907629","https://openalex.org/W2764328155","https://openalex.org/W2766999646","https://openalex.org/W2767839389","https://openalex.org/W2793677330","https://openalex.org/W2800034334","https://openalex.org/W2807396739","https://openalex.org/W4237502314","https://openalex.org/W4250416050"],"related_works":["https://openalex.org/W2767839389","https://openalex.org/W1532698890","https://openalex.org/W2346900422","https://openalex.org/W4205330508","https://openalex.org/W2013264850","https://openalex.org/W2674712403","https://openalex.org/W3205296335","https://openalex.org/W2971638573"],"abstract_inverted_index":{"Glycosylation":[0],"of":[1,10,23,34,45,60,68,78,92,99,145,168],"the":[2,13,24,43,46,73,89,96,143,159],"conserved":[3],"asparagine":[4],"residue":[5],"in":[6,12],"each":[7,100,146],"heavy":[8],"chain":[9],"IgG":[11],"CH2":[14],"domain":[15],"is":[16,21,80],"known":[17],"as":[18],"N-glycosylation.":[19],"It":[20],"one":[22],"most":[25],"common":[26],"post-translational":[27],"modifications":[28],"and":[29,54,58,75,84,119,134,140,153,166,181,190],"important":[30],"critical":[31],"quality":[32],"attributes":[33],"monoclonal":[35],"antibody":[36],"(mAb)":[37],"therapeutics.":[38],"Various":[39],"studies":[40,86],"have":[41],"demonstrated":[42,157],"effects":[44],"Fc":[47,51,62,150],"N-glycosylation":[48],"on":[49,149,175],"safety,":[50],"effector":[52,151],"functions,":[53],"pharmacokinetics,":[55],"both":[56],"dependent":[57],"independent":[59],"neonatal":[61],"receptor":[63],"(FcRn)":[64],"pathway.":[65],"However,":[66],"separation":[67],"various":[69],"glycoforms":[70,130],"to":[71,127,137],"investigate":[72],"biological":[74],"functional":[76],"relevance":[77],"glycosylation":[79],"a":[81],"major":[82],"challenge,":[83],"existing":[85],"often":[87],"discuss":[88],"overall":[90],"impact":[91,172],"N-glycans,":[93],"without":[94],"considering":[95],"individual":[97],"contributions":[98],"glycoform":[101],"when":[102],"evaluating":[103],"mAbs":[104],"with":[105,122,131],"highly":[106,132],"heterogeneous":[107],"distributions.":[108],"In":[109],"this":[110],"study,":[111],"chemoenzymatic":[112],"glycoengineering":[113],"incorporating":[114],"an":[115],"endo-\u03b2-N-acetylglucosaminidase":[116],"(ENGase)":[117],"EndoS2":[118],"its":[120],"mutant":[121],"transglycosylation":[123],"activity":[124],"was":[125],"used":[126],"generate":[128],"mAb":[129,170],"homogeneous":[133],"well-defined":[135],"N-glycans":[136,171],"better":[138],"understand":[139],"precisely":[141],"evaluate":[142],"effect":[144],"N-glycan":[147],"structure":[148],"functions":[152],"protein":[154,193],"stability.":[155],"We":[156],"that":[158],"core":[160],"fucosylation,":[161],"non-reducing":[162],"terminal":[163],"galactosylation,":[164],"sialylation,":[165],"mannosylation":[167],"IgG1":[169],"not":[173],"only":[174],"Fc\u03b3RIIIa":[176],"binding,":[177,183,187],"antibody-dependent":[178],"cell-mediated":[179],"cytotoxicity,":[180],"C1q":[182],"but":[184],"also":[185],"FcRn":[186],"thermal":[188],"stability":[189],"propensity":[191],"for":[192],"aggregation.":[194]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2901207337","counts_by_year":[{"year":2026,"cited_by_count":30},{"year":2025,"cited_by_count":26},{"year":2024,"cited_by_count":24},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":32},{"year":2021,"cited_by_count":35},{"year":2020,"cited_by_count":29},{"year":2019,"cited_by_count":12}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2018-11-29T00:00:00"}
